Isoprinosine Production Cost Reports

The report provides a detailed analysis essential for establishing an Isoprinosine production plant. It encompasses all critical aspects necessary for Isoprinosine production, including the cost of Isoprinosine production, Isoprinosine plant cost, Isoprinosine production costs, and the overall Isoprinosine production plant cost. Additionally, the study covers specific expenditures associated with setting up and operating an Isoprinosine production plant. These encompass production processes, raw material requirements, utility requirements, infrastructure needs, machinery and technology requirements, manpower requirements, packaging requirements, transportation requirements, and more.

Isoprinosine, also known as inosine pranobex, finds its primary industrial applications in pharmaceutical production as an immunomodulatory and antiviral agent for treating viral infections like herpes simplex, influenza, HPV-related conditions, and respiratory viruses. It also serves as an adjuvant in vaccines such as those for foot-and-mouth disease to enhance immune responses, including T-cell proliferation and cytokine production. Additionally, emerging uses include adjuvant therapy in oncology, chronic fatigue syndrome, COVID-19 management, and niche non-pharma roles like corrosion inhibition.

The market drivers for isoprinosine include the rising global prevalence of viral infections, which creates increasing demand for effective antiviral therapies. Growing awareness of isoprinosine's immunomodulatory benefits and its relatively mild side effect profile compared to other antivirals also contributes to market expansion. Additional drivers are increasing healthcare expenditures, especially in developing countries, improving healthcare infrastructure, and supportive government initiatives promoting antiviral drug development and accessibility.

Additionally, technological advancements in drug formulations and production processes enhance efficacy and patient compliance, further boosting market growth. Moreover, the hospital and clinic segment represents a major market share due to the high incidence of viral infections in these settings. Market factors such as price fluctuations in raw materials, availability of alternative antiviral drugs, and supply chain disruptions affect industrial Isoprinosine procurement strategies.

Raw Material for Isoprinosine Production

According to the Isoprinosine production plant project report, the various raw materials for Isoprinosine production include p-acetaminobenzoic acid and dimethylamino isopropanol.

Production Process of Isoprinosine

The extensive Isoprinosine production cost report consists of the following major industrial production process:

1. Production via esterification reaction: The production process of Isoprinosine occurs through a two-step process starting with the esterification of p-acetaminobenzoic acid (acetaminophenzoic acid) with dimethylamino isopropanol. The reaction takes place in dehydrated ethanol at 40-50 degree Celsius for about 2 hours, yielding dimethylamino isopropanol-p-acetaminobenzoate as a white crystalline intermediate after cooling, filtration, ethyl acetate washing, drying, and recrystallisation. This intermediate then reacts with inosine in a 1:3 molar ratio, typically in ethanol or ethyl acetate with azeotropic dehydration, under stirring and reduced pressure evaporation, followed by suspension, separation, washing, and drying to produce Isoprinosine.

Properties of Isoprinosine

Isoprinosine is a white to off-white, odourless, tasteless crystalline powder with a molecular formula of C52H78N10O17, molecular weight of 1,115.2 g/mol, and melting point of 140-142 degree Celsius. It exhibits slight solubility in water, DMSO (14 mg/mL heated), methanol, DMF (2 mg/mL), and PBS (pH 7.2, 10 mg/mL), while being hygroscopic and stable under inert gas at room temperature or -20 degree Celsius.

It is a synthetic purine derivative comprising inosine and dimepranol acedoben in a 1:3 ratio. It is non-flammable with a boiling point around 732.8 degree Celsius at 760 mmHg, specific rotation of -9.0 to -14.0° (c=1, H₂O), and purity >98% by HPLC, characterised by X-ray diffraction, UV-Vis, IR, NMR, and mass spectrometry for pharmaceutical compliance. It demonstrates high stability without hazardous decomposition, supporting its use in oral formulations.